These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20196485)

  • 1. [Insulin allergy whose local/systemic reactions were reduced by desensitization with long-acting insulin analog, glargine].
    Tuboi M; Tsuchiya T; Taguchi R; Tanaka Y; Iwasaki Y; Hashimoto K; Kakizaki S; Okada S; Shimizu H; Mori M
    Nihon Naika Gakkai Zasshi; 2010 Jan; 99(1):133-5. PubMed ID: 20196485
    [No Abstract]   [Full Text] [Related]  

  • 2. Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glargine.
    Wu P; Ji C; Wang M; Zou S; Ge W
    Ann Endocrinol (Paris); 2013 Feb; 74(1):56-8. PubMed ID: 23351561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful desensitization by glargine administration in a patient with insulin allergy: a case report.
    Hara M; Izumida Y; Sato N; Ohashi K; Osuga J; Tobe K; Tsukamoto K; Kadowaki T
    Diabetes Res Clin Pract; 2009 Jun; 84(3):e48-9. PubMed ID: 19286270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful desensitization in patient with type 2 diabetes with an insulin allergy using insulin pump and glargine.
    Petrovski G; Zivkovic M; Milenkovic T; Ahmeti I; Bitovska I
    Acta Diabetol; 2014 Dec; 51(6):1073-5. PubMed ID: 24811944
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of insulin allergy in a 1-year-old infant with neonatal diabetes by lispro and glargine insulin.
    Kara C; Kutlu AO; Evliyaoglu O; Bilgili H; Yildirim N
    Diabetes Care; 2005 Apr; 28(4):983-4. PubMed ID: 15793215
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs.
    Mollar-Puchades MA; Villanueva IL
    Diabetes Res Clin Pract; 2009 Jan; 83(1):e21-2. PubMed ID: 19070911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin glargine: a new basal insulin analogue.
    Younis N; Soran H; Bowen-Jones D
    QJM; 2002 Nov; 95(11):757-61. PubMed ID: 12391389
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin combination therapy in type 2 diabetes mellitus.
    Hassan Y; Gupta G; Hassan S
    Ann Intern Med; 2004 Apr; 140(8):666; author reply 667. PubMed ID: 15096346
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimizing glycemic control with insulin glargine.
    Williams JB
    Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin glargine in continuous enteric tube feeding.
    Putz D; Kabadi UM
    Diabetes Care; 2002 Oct; 25(10):1889-90. PubMed ID: 12351503
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin combination therapy in type 2 diabetes mellitus.
    Mikhail N; Wali S
    Ann Intern Med; 2004 Apr; 140(8):666-7; author reply 667. PubMed ID: 15096347
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetic retinopathy and insulin glargine.
    Chantelau E
    Diabetologia; 2009 Oct; 52(10):2233; author reply 2236-9. PubMed ID: 19680626
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment with human analog (GlyA21, ArgB31, ArgB32) insulin glargine (HOE901) resolves a generalized allergy to human insulin in type 1 diabetes.
    Moriyama H; Nagata M; Fujihira K; Yamada K; Chowdhury SA; Chakrabarty S; Jin Z; Yasuda H; Ueda H; Yokono K
    Diabetes Care; 2001 Feb; 24(2):411-2. PubMed ID: 11213905
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiating basal insulin therapy in patients with type 2 diabetes mellitus.
    Stoneking K
    Am J Health Syst Pharm; 2005 Mar; 62(5):510-8. PubMed ID: 15745915
    [No Abstract]   [Full Text] [Related]  

  • 16. The fallacy of hindsight: response to Moses and Koenen.
    Holleman F; DeVries JH
    Diabetes Technol Ther; 2010 Oct; 12(10):833-4. PubMed ID: 20809683
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial: glargine, a new long-acting insulin analog for diabetic cats.
    Rand J
    J Vet Intern Med; 2006; 20(2):219-20. PubMed ID: 16594574
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful Treatment of Insulin Allergy with Desensitization Therapy: A Case Report and Literature Review.
    Elfekih H; Hadjkacem F; Elleuch M; Ghorbel D; Charfi N; Mnif F; Rekik N; Mnif M; Abid M
    Iran J Allergy Asthma Immunol; 2019 Oct; 18(5):572-583. PubMed ID: 32245301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can glargine reduce the number of lung infections in patients with cystic fibrosis-related diabetes?
    Franzese A; Spagnuolo MI; Sepe A; Valerio G; Mozzillo E; Raia V
    Diabetes Care; 2005 Sep; 28(9):2333. PubMed ID: 16123520
    [No Abstract]   [Full Text] [Related]  

  • 20. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients: response to Rosenstock et al.
    Hamid Z; Simmons DL
    Diabetes Care; 2006 Oct; 29(10):2331; author reply 2332. PubMed ID: 17003324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.